ANCA-MPO ANTI MYELOPEROXIDASE ANTIBODIES EIA Test
At DNA Labs UAE, we offer the ANCA-MPO ANTI MYELOPEROXIDASE ANTIBODIES EIA Test to help diagnose and monitor autoimmune diseases, particularly those involving small vessel vasculitis. This test detects the presence of anti-myeloperoxidase antibodies in a patient’s blood, which are associated with certain autoimmune diseases.
Test Details
The ANCA-MPO (anti-myeloperoxidase antibodies) EIA (enzyme immunoassay) test is a diagnostic tool used to detect the presence of anti-myeloperoxidase antibodies in a patient’s blood. Myeloperoxidase is an enzyme found in neutrophils, a type of white blood cell. The EIA test works by coating a microplate with purified myeloperoxidase antigen. Patient serum is then added to the plate, and if anti-myeloperoxidase antibodies are present in the serum, they will bind to the antigen. After washing away unbound components, an enzyme-labeled secondary antibody is added, which will bind to the anti-myeloperoxidase antibodies if they are present. Finally, a substrate is added that produces a color change if the enzyme is present, indicating the presence of anti-myeloperoxidase antibodies in the patient’s serum.
The ANCA-MPO EIA test is a useful tool in diagnosing and monitoring certain autoimmune diseases, particularly those involving small vessel vasculitis. It can help differentiate between different types of vasculitis and guide treatment decisions. However, it is important to note that the presence of anti-myeloperoxidase antibodies alone is not sufficient for a diagnosis, and clinical correlation is necessary. Other tests, such as ANCA (antineutrophil cytoplasmic antibodies) immunofluorescence, may also be used in conjunction with the ANCA-MPO EIA test to provide a more comprehensive evaluation.
Test Name: ANCA-MPO ANTI MYELOPEROXIDASE ANTIBODIES EIA Test
Components: Corresponds with p-ANCA
Price: 430.0 AED
Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is preferred.
Report Delivery: SampleTue / Thu / Sat by 9 am; Report Same day
Method: Enzyme Immunoassay
Test Type: Autoimmune disorders
Doctor: Nephrologist, Physician, Neurologist
Test Department:
Pre Test Information: Overnight fasting is preferred.
| Test Name | ANCA-MPO ANTI MYELOPEROXIDASE ANTIBODIES EIA Test |
|---|---|
| Components | Corresponds with p-ANCA |
| Price | 430.0 AED |
| Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is preferred. |
| Report Delivery | SampleTue / Thu / Sat by 9 am; Report Same day |
| Method | Enzyme Immunoassay |
| Test type | Autoimmune disorders |
| Doctor | Nephrologist, Physician, Neurologist |
| Test Department: | |
| Pre Test Information | Overnight fasting is preferred. |
| Test Details |
The ANCA-MPO (anti-myeloperoxidase antibodies) EIA (enzyme immunoassay) test is a diagnostic tool used to detect the presence of anti-myeloperoxidase antibodies in a patient’s blood. Myeloperoxidase is an enzyme found in neutrophils, a type of white blood cell. The presence of anti-myeloperoxidase antibodies is associated with certain autoimmune diseases, particularly small vessel vasculitis, such as microscopic polyangiitis and Churg-Strauss syndrome. The EIA test works by coating a microplate with purified myeloperoxidase antigen. Patient serum is then added to the plate, and if anti-myeloperoxidase antibodies are present in the serum, they will bind to the antigen. After washing away unbound components, an enzyme-labeled secondary antibody is added, which will bind to the anti-myeloperoxidase antibodies if they are present. Finally, a substrate is added that produces a color change if the enzyme is present, indicating the presence of anti-myeloperoxidase antibodies in the patient’s serum. The ANCA-MPO EIA test is a useful tool in diagnosing and monitoring certain autoimmune diseases, particularly those involving small vessel vasculitis. It can help differentiate between different types of vasculitis and guide treatment decisions. However, it is important to note that the presence of anti-myeloperoxidase antibodies alone is not sufficient for a diagnosis, and clinical correlation is necessary. Other tests, such as ANCA (antineutrophil cytoplasmic antibodies) immunofluorescence, may also be used in conjunction with the ANCA-MPO EIA test to provide a more comprehensive evaluation. |
